| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | C-C motif chemokine 3|G0/G1 switch regulatory protein 19-1|Macrophage inflammatory protein 1-alpha|MIP-1-alpha|PAT 464.1|SIS-beta|Small-inducible cytokine A3|Tonsillar lymphocyte LD78 alpha protein|MIP-1-alpha(4-69|LD78-alpha(4-69|CCL3|G0S19-1|MIP1A|SCYA3 |
| Assay Time | |
| Detection Method | |
| Detection Range | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples |
| Sensitivity | |
| Species | |
| Storage | |
| Target | |
| UniProt # |
Background
rat MIP-1α/CCL3 (Macrophage Inflammatory Protein 1 Alpha) is a molecular target commonly studied in immunology research. Chemokines are small secreted proteins that guide immune-cell trafficking and shape inflammatory microenvironments.
Biological role and mechanism
The biological role of MIP-1α/CCL3 is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.
Expression and abundance of MIP-1α/CCL3 can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.
Nomenclature and related terms
MIP-1α/CCL3 (Macrophage Inflammatory Protein 1 Alpha) may also be referenced as C-C motif chemokine 3, G0/G1 switch regulatory protein 19-1, and Macrophage inflammatory protein 1-alpha in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).
Why it matters in research
- Understanding how MIP-1α/CCL3 relates to innate and adaptive immune responses, cytokine signaling networks, host–pathogen interactions, and immune cell activation and trafficking in immunology research.
- Interpreting shifts in MIP-1α/CCL3 levels alongside other pathway components or complementary markers.
- Connecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).
Molecular forms and interpretation
For some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.
Disease and translational relevance
MIP-1α/CCL3 has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with immunology studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Hydrogel loaded with cerium-manganese nanoparticles and nerve growth factor enhances spinal cord injury repair by modulating immune microenvironment and promoting neuronal regeneration
IF: 10.6 Journal: Journal of Nanobiotechnology Author: Department of Orthopedics, Huashan Hospital, Fudan University, No. 12, Middle Wulumuqi Road, Jing'an District, Shanghai, 200040, China. Cited Date: 2025-02-14
The RLR/NLR expression and pro-inflammatory activity of tissue mast cells are regulated by cathelicidin LL-37 and defensin hBD-2
IF: 4.847 Journal: Scientific Reports Cited Date: 2018-08-12
Multilayered Nanocarriers as a New Strategy for Delivering Drugs with Protective and Anti-inflammatory Potential: Studies in Hippocampal Organotypic Cultures Subjected to Experimental Ischemia
IF: 4.6 Journal: Molecular Neurobiology Author: Laboratory of Immunoendocrinology Department of Experimental Neuroendocrinology, Maj Institute of Pharmacology, Polish Academy of Sciences, 12 Sm?tna St, 31-343, Kraków, Poland. Cited Date: 2025-01-24
The impact of TLR7 agonist R848 treatment on mast cell phenotype and activity
IF: 4.078 Journal: Cellular Immunology Cited Date: 2020-11-19
Neuroprotective and anti-neuropathic actions of pulsed magnetic fields with low frequencies in rats with chronic peripheral neuropathic pain
IF: 4.077 Journal: Brain Research Bulletin Cited Date: 2021-11-25